Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 20:11 source : Www.biospace.com save search
Jazz Pharmaceuticals Announces Initiation of Biologics License Application Submission for JZP-458 for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Published: 2020-12-21 (Crawled : 20:11) - biospace.com/
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -1.63%
H: 2.32%
C: 1.34%
license leukemia submission treatment
Onconova Therapeutics Announces FDA Permission for Study to Proceed Under its Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor
Published: 2020-12-21 (Crawled : 20:11) - biospace.com/
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 7.89%
H: 0.98%
C: -11.24%
fda drug new drug application
Evofem Biosciences to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Published: 2020-12-21 (Crawled : 20:11) - biospace.com/
EVFM | $0.0141 -16.94% 180K
|
Health Technology
|
| O: -0.95%
H: 2.87%
C: 2.87%
bioscience
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical OfficerEquillium Further Strengthens Management Team with Additional Executive Hires
Published: 2020-12-21 (Crawled : 20:11) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.66%
H: 0.13%
C: -0.63%
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: -0.4%
H: 0.2%
C: -3.85%
research
Edwards Treats First Patient In U.S. Clinical Trial Evaluating Minimally Invasive Device For Mitral Valve Disease
Published: 2020-12-21 (Crawled : 20:11) - biospace.com/
EW | $85.94 -0.59% 0.0% 3.9M
|
Health Technology
|
| O: -1.88%
H: 0.66%
C: 0.53%
disease trial device
Bio-Techne To Present At The 39th Annual J.P. Morgan Healthcare Conference
Published: 2020-12-21 (Crawled : 20:11) - biospace.com/
TECH | $62.12 -0.15% -0.14% 910K
|
Health Technology
|
| O: -0.87%
H: 1.76%
C: 1.39%
j.p. morgan healthcare conference
9 Meters Biopharma Announces Agreement with the European Biomedical Research Institute of Salerno (EBRIS) to Continue Evaluation of Larazotide for COVID-19 Respiratory Complications
Published: 2020-12-21 (Crawled : 20:11) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: -8.71%
H: 10.63%
C: 10.63%
covid biopharma research respiratory
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.